F5, Inc.: Form 10-Q for the period ended Mar 31, 2020
Filed with the SEC on May 6, 2020 and accepted by EDGAR at May 6, 2020, 16:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-01-01 to 2020-03-31 | $583.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2019-10-01 to 2020-03-31 | $1.15bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-01-01 to 2020-03-31 | $101.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2019-10-01 to 2020-03-31 | $189.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-01-01 to 2020-03-31 | $482.2m | us-gaap:GrossProfit |
| Gross profit | 6 months2019-10-01 to 2020-03-31 | $962.9m | us-gaap:GrossProfit |
| Research and development | 3 months2020-01-01 to 2020-03-31 | $109.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2019-10-01 to 2020-03-31 | $205.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-01-01 to 2020-03-31 | $83.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-10-01 to 2020-03-31 | $206.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-01-01 to 2020-03-31 | $22.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2019-10-01 to 2020-03-31 | $51.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-01-01 to 2020-03-31 | $61.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-10-01 to 2020-03-31 | $159.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-01-01 to 2020-03-31 | $1.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2019-10-01 to 2020-03-31 | $2.62 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-01-01 to 2020-03-31 | $1.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2019-10-01 to 2020-03-31 | $2.63 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-01-01 to 2020-03-31 | 61,084,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2019-10-01 to 2020-03-31 | 61,017,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2019-10-01 to 2020-03-31 | $325.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2019-10-01 to 2020-03-31 | $35.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2019-10-01 to 2020-03-31 | $50.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-03-31 | $572.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-03-31 | $1.41bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-03-31 | $4.44bn | us-gaap:Assets |
| Current liabilities | At period end2020-03-31 | $1.25bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2020-03-31 | $378.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-03-31 | $19.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2020-03-31 | $2.00bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0001048695-20-000027. Last ingested by Listed: Nov 10, 2026, 04:33 ET. Listed shows no prices and gives no investment advice.